ATR Aptargroup (ATR) Insider Trading, Ownership & Congress Trades
Materials · Plastics products, nec · CIK 0000896622
Form 144 · 5
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
271
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $829.6K priced
What the filings say about ATR
Insiders, 180 days
-$5.2M net sold
7 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: purchase, 2025-06-24
Planned sales (Form 144), 90 days
$3.6M
5 notices
Aptargroup insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, APTARGROUP, INC. insiders sold a net $5.2M of stock across 86 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Jun 4, 2026.
- The trade is 2.9% of the 26,313 shares held after it.
- 4 other insiders sold within 30 days.
- 271 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer Vinczeller Shiela sold about $99.7K of ATR on Sep 2, 2026; 4 other insiders sold within 30 days and 271 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Feb 18, 2026.
- The trade is 11.6% of the 29,427 shares held after it.
- 4 other insiders sold within 30 days.
- 271 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Segment Pres., CEO Designate Touya Gael sold about $456.5K of ATR on Aug 27, 2026; 4 other insiders sold within 30 days and 271 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Feb 18, 2026.
- The trade is 1.1% of the 29,102 shares held after it.
- 4 other insiders sold within 30 days.
- 271 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Segment Pres., CEO Designate Touya Gael sold about $43.7K of ATR on Aug 27, 2026; 4 other insiders sold within 30 days and 271 funds added in the latest 13F quarter.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Jun 9, 2026.
- The trade is 21.2% of the 15,947 shares held after it.
- 4 other insiders sold within 30 days.
- 271 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Segment President Prieur Marc sold about $459.9K of ATR on Aug 4, 2026; 4 other insiders sold within 30 days and 271 funds added in the latest 13F quarter.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Jun 9, 2026.
- The trade is 0.8% of the 15,823 shares held after it.
- 4 other insiders sold within 30 days.
- 271 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Segment President Prieur Marc sold about $17.0K of ATR on Aug 4, 2026; 4 other insiders sold within 30 days and 271 funds added in the latest 13F quarter.86 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$5.2M over 180 days
-$3.6M over 90 days
below 89% of Materials
Congress
no House purchase disclosed in the last 12 months
Funds
271 funds bought in last quarter
more than 81% of Materials
Revenue
+5.4% year over year
more than 66% of Materials
Margin
10.4% net margin
more than 82% of Materials
Buybacks
$150.0M repurchased, FY to 2026-06-30
more than 74% of Materials
Short interest
3.3% of the float short (float per yahoo 2026-10-26) · 4.4 days to cover · settled 2026-09-30
below 57% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ATR
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-2.2%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ATR: institutional holders (13F)
13F holdings, latest reported quarter
6,137,894 sh
$768.5M
4,744,564 sh
$594.0M
3,638,724 sh
$455.6M
3,523,908 sh
$441.2M
2,893,751 sh
$362.3M
Congress trades in ATR
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2025-06-24 · disclosed 50 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ATR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
SHIELA PALLERNE VINCZELLER
Filed 2026-09-02
$99.7K
GAEL TOUYA
Filed 2026-08-27
$500.3K
Prieur Marc
Filed 2026-08-04
$476.0K
HEDI TLILI
Filed 2026-08-03
$1.2M
STEPHAN B TANDA
Filed 2026-08-03
$1.3M
ATR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FMI Common Stock Fund
$87.0M position · as of 2026-06-30
4.6%
AMG River Road Focused Absolute Value Fund
$1.8M position · as of 2026-07-31
4.0%
BBH Select Mid Cap ETF
$14.7M position · as of 2026-07-31
3.3%
GMO Small Cap Quality Fund
$22.5M position · as of 2026-05-31
3.2%
AMG River Road Small-Mid Cap Value Fund
$10.9M position · as of 2026-07-31
3.2%
Nomura Mid Cap Income Opportunities Fund
$20.0M position · as of 2026-06-30
2.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Health And Human Services
RESEARCH CHALLENGES RELATED TO ENVIRONMENTALLY FRIENDLY PROPELLANTS IN METERED DOSE INHALERS · 2023-09-20
$3.4M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$10.2M
$661.8K
$3.0M
-5%
-14%
2024
$9.9M
$23.8M
$2.9M
+21%
-13%
2023
$8.9M
$12.9M
$3.0M
-6%
-13%
2022
$8.8M
$6.9M
$2.8M
-18%
-8%
2021
$9.4M
-$2.8M
$3.2M
-10%
+24%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $5.2M sold by insiders over 180 days, 271 funds added last quarter, $3.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ATR financials
Revenue growth
+5.4%
XBRL, annual
Net margin
10.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ATR
| FY Dec 2025 | $3.8B |
| FY Dec 2024 | $3.6B |
| FY Dec 2023 | $3.5B |
| FY Dec 2022 | $3.3B |
| FY Dec 2021 | $3.2B |
| Jun 2026 | $1.0B |
| Mar 2026 | $982.9M |
| Dec 2025 | $962.7M |
| Sep 2025 | $961.1M |
| Jun 2025 | $966.0M |
| Mar 2025 | $887.3M |
| Dec 2024 | $848.1M |
| Sep 2024 | $909.3M |
At each fiscal year end
Single quarter
Net margin, TTM
+9.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ATR
| FY Dec 2025 | +10.4% |
| FY Dec 2024 | +10.5% |
| FY Dec 2023 | +8.2% |
| FY Dec 2022 | +7.2% |
| FY Dec 2021 | +7.6% |
| Jun 2026 | +8.5% |
| Mar 2026 | +7.4% |
| Dec 2025 | +7.7% |
| Sep 2025 | +13.3% |
| Jun 2025 | +11.6% |
| Mar 2025 | +8.9% |
| Dec 2024 | +11.9% |
| Sep 2024 | +11.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$310.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ATR
| FY Dec 2025 | $299.6M |
| FY Dec 2024 | $366.9M |
| FY Dec 2023 | $262.9M |
| FY Dec 2022 | $168.2M |
| FY Dec 2021 | $55.5M |
| Jun 2026 | $45.9M |
| Mar 2026 | $53.3M |
| Dec 2025 | $96.9M |
| Sep 2025 | $114.3M |
| Jun 2025 | $62.5M |
| Mar 2025 | $25.9M |
| Dec 2024 | $112.2M |
| Sep 2024 | $162.7M |
At each fiscal year end
Single quarter
Debt to equity
0.51x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity ATR
| FY Dec 2025 | 0.50x |
| FY Dec 2024 | 0.35x |
| FY Dec 2023 | 0.33x |
| FY Dec 2022 | 0.51x |
| FY Dec 2021 | 0.54x |
| Jun 2026 | 0.51x |
| Mar 2026 | 0.51x |
| Dec 2025 | 0.50x |
| Sep 2025 | 0.33x |
| Jun 2025 | 0.30x |
| Mar 2025 | 0.28x |
| Dec 2024 | 0.35x |
| Sep 2024 | 0.41x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.44x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt ATR
| FY Dec 2025 | 0.43x |
| FY Dec 2024 | 0.74x |
| FY Dec 2023 | 0.75x |
| FY Dec 2022 | 0.45x |
| FY Dec 2021 | 0.34x |
| Jun 2026 | 0.44x |
| Mar 2026 | 0.45x |
| Dec 2025 | 0.43x |
| Sep 2025 | 0.62x |
| Jun 2025 | 0.77x |
| Mar 2025 | 0.88x |
| Dec 2024 | 0.74x |
| Sep 2024 | 0.65x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+13.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ATR
| FY Dec 2025 | +15.3% |
| FY Dec 2024 | +15.7% |
| FY Dec 2023 | +13.0% |
| FY Dec 2022 | +11.9% |
| FY Dec 2021 | +12.8% |
| Jun 2026 | +13.6% |
| Mar 2026 | +15.0% |
| Dec 2025 | +15.3% |
| Sep 2025 | +15.8% |
| Jun 2025 | +15.4% |
| Mar 2025 | +15.2% |
| Dec 2024 | +15.7% |
| Sep 2024 | +14.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ATR
| FY Dec 2025 | +8.1% |
| FY Dec 2024 | +8.4% |
| FY Dec 2023 | +6.6% |
| FY Dec 2022 | +5.7% |
| FY Dec 2021 | +6.0% |
| Jun 2026 | +7.3% |
| Mar 2026 | +8.0% |
| Dec 2025 | +8.1% |
| Sep 2025 | +8.6% |
| Jun 2025 | +8.4% |
| Mar 2025 | +8.3% |
| Dec 2024 | +8.4% |
| Sep 2024 | +7.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+10.0%
operating income after a 20.2% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital ATR
| FY Dec 2025 | +11.2% |
| FY Dec 2024 | +13.1% |
| FY Dec 2023 | +11.1% |
| FY Dec 2022 | +9.2% |
| FY Dec 2021 | +9.6% |
| Jun 2026 | +10.0% |
| Mar 2026 | +10.7% |
| Dec 2025 | +11.2% |
| Sep 2025 | +12.8% |
| Jun 2025 | +13.0% |
| Mar 2025 | +13.0% |
| Dec 2024 | +13.1% |
| Sep 2024 | +11.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ATR
| FY Dec 2025 | +13.5% |
| FY Dec 2024 | +15.1% |
| FY Dec 2023 | +12.5% |
| FY Dec 2022 | +11.8% |
| FY Dec 2021 | +10.9% |
| Jun 2026 | +12.7% |
| Mar 2026 | +13.5% |
| Dec 2025 | +13.5% |
| Sep 2025 | +14.3% |
| Jun 2025 | +15.2% |
| Mar 2025 | +15.2% |
| Dec 2024 | +15.1% |
| Sep 2024 | +13.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.84x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ATR
| FY Dec 2025 | 20.67x |
| FY Dec 2024 | 28.41x |
| FY Dec 2023 | 29.09x |
| FY Dec 2022 | 30.72x |
| FY Dec 2021 | 33.93x |
| Jun 2026 | 22.60x |
| Mar 2026 | 21.54x |
| Dec 2025 | 20.67x |
| Sep 2025 | 21.42x |
| Jun 2025 | 26.97x |
| Mar 2025 | 27.13x |
| Dec 2024 | 28.41x |
| Sep 2024 | 32.17x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$9.2B
market value at close 2026-10-27 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value ATR
| FY Dec 2025 | $8.9B |
| FY Dec 2024 | $11.1B |
| FY Dec 2023 | $8.7B |
| FY Dec 2022 | $8.1B |
| FY Dec 2021 | $9.0B |
| Jun 2026 | $9.1B |
| Mar 2026 | $9.2B |
| Dec 2025 | $8.9B |
| Sep 2025 | $9.5B |
| Jun 2025 | $11.0B |
| Mar 2025 | $10.5B |
| Dec 2024 | $11.1B |
| Sep 2024 | $11.4B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield ATR
| FY Dec 2025 | +3.7% |
| FY Dec 2024 | +3.5% |
| FY Dec 2023 | +3.2% |
| FY Dec 2022 | +2.3% |
| FY Dec 2021 | +0.7% |
| Jun 2026 | +3.9% |
| Mar 2026 | +4.0% |
| Dec 2025 | +3.7% |
| Sep 2025 | +3.6% |
| Jun 2025 | +3.5% |
| Mar 2025 | +3.8% |
| Dec 2024 | +3.5% |
| Sep 2024 | +3.7% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -4%, PEG needs growth
PEG, trailing ATR
| FY Dec 2025 | 3.09x |
| FY Dec 2024 | 0.94x |
| FY Dec 2023 | 1.55x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 2.72x |
| Jun 2026 | n/a |
| Mar 2026 | 3.10x |
| Dec 2025 | 3.09x |
| Sep 2025 | 0.85x |
| Jun 2025 | 1.23x |
| Mar 2025 | 1.56x |
| Dec 2024 | 0.94x |
| Sep 2024 | 1.76x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $3.8B | $3.6B | $3.5B | $3.3B |
| Operating income | $501.0M | $496.5M | $404.0M | $379.3M |
| Net income | $392.8M | $374.5M | $284.5M | $239.3M |
| EPS (diluted) | 5.89 | 5.53 | 4.25 | 3.59 |
| Operating cash flow | $570.0M | $643.4M | $575.2M | $478.6M |
| Cash | $402.4M | $223.8M | $223.6M | $141.7M |
| Long-term debt | $1.1B | $688.1M | $681.2M | $1.1B |
| Buybacks | $365.0M | $68.6M | $47.6M | $92.1M |
| Dividends paid | $120.8M | $114.1M | $103.7M | $99.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
ATR Stock Sonar score 6/7 axes
Find similar shapesCompareATR ranks highest on financial health (74th percentile) and growth (70th), and lowest on insider conviction (6th), among Materials peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ATR filings, in plain words
Are Aptargroup insiders buying or selling ATR?
In the 180 days to 2026-10-28, Aptargroup insiders were net sellers, a net $5.2M across purchases and sales reported on Form 4, by 7 sellers.
Have members of Congress traded ATR?
Yes, but not in the year to 2026-10-28; the latest on record is a purchase by Lisa McClain dated 2025-06-24.
Are there planned insider sales of ATR?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $3.6M of stock; the latest, by SHIELA PALLERNE VINCZELLER, was filed 2026-09-02.
Read the full summary
In the 180 days to 2026-10-28, Aptargroup insiders were net sellers of ATR, a net $5.2M across purchases and sales reported on Form 4 by 7 sellers. None of the 15 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in ATR, none in the last year; the latest on record is a purchase by Lisa McClain dated 2025-06-24. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $3.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
